Tech Company Financing Transactions
OncoCell MDx Funding Round
OncoCell MDx, based in Corvallis, secured $22.2 million from Savitr Capital and private investors.
Transaction Overview
Company Name
Announced On
9/12/2019
Transaction Type
Venture Equity
Amount
$22,200,000
Round
Series B
Investors
Savitr Capital (Lead Investor) (Andrew Midler)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
582 NW Van Buren Ave.
Corvallis, OR 97330
USA
Corvallis, OR 97330
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark McDonough
Chief Medical Officer
Kirk Wojno
Chief Operating Officer
Christopher Thibodeau
Founder
Harry Stylli
VP - Bus. Development
Geoffrey Erickson
Browse more venture capital transactions:
Prev: 9/12/2019: Voxpopme venture capital transaction
Next: 9/12/2019: MedMinder Systems venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs